Related Experiment Video

Updated: Mar 25, 2026

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

3.1K

PRDM players in central nervous system cancers: State of the art and future perspectives

Erika Di Zazzo1, Marzia Di Donato2, Monica Rienzo3

  • 1Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso 86100, Italy.

Critical Reviews in Oncology/Hematology
|March 23, 2026
PubMed

Insights

PRDM proteins are key regulators in brain cancers, offering potential as diagnostic biomarkers and therapeutic targets for improved treatment strategies.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Brain cancer diagnosis and treatment face significant challenges despite molecular understanding.
  • PRDM (PRDI-BF1 and RIZ domain-containing) proteins are emerging regulators in various cancers, including brain cancers.
  • Current knowledge on PRDM proteins' role in central nervous system malignancies is limited.

Purpose of the Study:

  • To review the involvement of PRDM proteins in central nervous system malignancies.
  • To explore the potential of PRDM proteins as diagnostic and prognostic biomarkers for brain cancers.
  • To discuss therapeutic strategies targeting PRDM proteins and their associated pathways.

Main Methods:

  • Literature review of current research on PRDM proteins in brain cancers.
  • Analysis of PRDM protein functions in central nervous system malignancies.
  • Exploration of therapeutic approaches modulating PRDM proteins.

Main Results:

  • PRDM proteins are implicated as significant determinants in brain cancers.
  • PRDM proteins show potential as diagnostic and prognostic biomarkers.
  • Targeting PRDM proteins offers novel therapeutic avenues.

Conclusions:

  • PRDM proteins are promising candidates for next-generation, mechanism-based brain cancer interventions.
  • Modulating PRDM proteins could optimize brain cancer treatment strategies.
  • Further research into PRDM proteins is crucial for advancing neuro-oncology.
Keywords:
CancerGlioblastomaGliomaMedulloblastomaPRDM

More Related Videos

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery07:43

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on: August 23, 2016

10.5K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K